This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024
Secure Your Spot
Menu
BOOK NOW

Aneesh Karatt Vellatt, PhD
Chief Scientific Officer at Maxion Therapeutics
Speaker

Profile

Dr. Aneesh Karatt Vellatt is Chief Scientific officer and co-founder at Maxion Therapeutics Ltd, a company focused on developing antibody treatments for diseases driven by ion channels and GPCRs. Dr Karatt Vellatt was also co-founder of IONTAS Ltd and holds a PhD in Biochemistry from the University of Cambridge.

Agenda Sessions

  • KnotBodies; Creating Ion Channel Modulating Antibodies by Fusing Knottins into Antibody Loops

    , 9:15am
    View Session

At this event

Prev
Next
Kristel Kemper, Ph.D.
Director, Translational Research
Genmab

See Aneesh at Antibody Engineering & Therapeutics US

Secure Your Spot